Rare Disease Trial, Recruiting NCT07575347 Sponsor: Stefan Lujinschi Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT07575347
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are able to read and sign a consent form agreeing to take part in the study
  • You have at least 10 of your own natural teeth
  • You belong to one of the following groups: you have Alport syndrome (confirmed by genetic testing or medical diagnosis); you have Fabry disease (confirmed by enzyme testing or genetic testing); you have Tuberous Sclerosis Complex (confirmed by medical or genetic criteria); you have Systemic Lupus Erythematosus (lupus) that also affects your kidneys, shown by a kidney biopsy, persistent protein in your urine, or certain findings in your urine tests; you have chronic kidney disease that is not caused by a rare condition, based on standard medical measurements of kidney function or signs of kidney damage; or you do not have chronic kidney disease and are being recruited as a comparison participant from a clinic or dental setting

Who may not be able to join:

  • You have had gum (periodontal) treatment in the last 6 months
  • You have taken antibiotics in the last 4 weeks
  • You are currently pregnant
  • You have a condition that would make a gum examination impossible or unsafe (confirm with trial site)
  • You are unable to follow the study procedures for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gener Ismail, Professor, MD, PhD, Fundeni Clinical Institute

Phone: +40728102643

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Stefan Lujinschi
Registry
ClinicalTrials.gov
Start date
4 May 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇷🇴 Romania

Primary endpoints

Prevalence of Periodontitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov